JB Capital’s CME Group CME Stock Holding History

JB Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-846	Closed	-$202K	–	232
2022 Q1	$202K	Sell	846 -111	-12%	-$26.1K	0.02%	235
2021 Q4	$219K	Buy	+957	New	+$211K	0.02%	239

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JB Capital's CME Position: Q2 2022 in Review

JB Capital sold out of CME Group (CME) in Q2 2022, closing a stake of 846 shares — an estimated $202K sold.

JB Capital first reported a position in CME in Q4 2021 and held it in 2 quarters. The position peaked at $219K in Q4 2021. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

JB Capital reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
JB Capital sold 846 CME Group shares in Q2 2022, an estimated $202K.
JB Capital first reported a position in CME Group in Q4 2021 and held it in 2 quarters.
JB Capital's CME Group position peaked at $219K in Q4 2021.
1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on JB Capital's 13F filing for Q2 2022, filed 28 Jul 2022.